Workflow
INVO BioScience(INVO)
icon
Search documents
INVO BioScience(INVO) - 2019 Q3 - Quarterly Report
2019-11-14 14:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE Commission file number 000-56094 INVO Bioscience, Inc. (Exact name of registrant as specified in its charter) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Se ...
INVO BioScience(INVO) - 2019 Q2 - Quarterly Report
2019-08-14 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Nevada 20-4036208 (I.R.S. Employer Identification No.) 5582 Broadcast Court Sarasota, Florida, 34240 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC ...
INVO BioScience(INVO) - 2019 Q1 - Quarterly Report
2019-05-15 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Nevada 20-4036208 (I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation or organization) 407 Rear Mystic Avenue, Suite 34C, Medford, MA 02155 (Address of principal executive offices, including zip code) For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...
INVO BioScience(INVO) - 2018 Q4 - Annual Report
2019-04-16 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to INVO BIOSCIENCE, INC. (Exact name of registrant as specified in Charter) Nevada 333-147330 20-4036208 (State or other jurisdiction of incorporation or organization) (Commi ...